Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

415.21 -2.63 (-0.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
69 70 Next >
News headline image
Investors Like Certainty. Trump's Win Gave Them Some. ↗
We're also talking about Super Micro, Nvidia, and weight loss. 
Via The Motley Fool
Topics Government
News headline image
AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis ↗
AstraZeneca and Amgen's Phase 3 trial data shows Tezspire significantly reduces nasal polyps and congestion in patients with chronic rhinosinusitis with nasal polyps. 
Via Benzinga
News headline image
3 Healthcare Stocks For Long-Term Growth And Dividends ↗
Healthcare stocks will profit from the U.S. aging population and pay rising dividends over time. 
Via Talk Markets
News headline image
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say ↗
Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics market. 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
A Closer Look at Amgen's Options Market Dynamics ↗
 
Via Benzinga
News headline image
Navigating 14 Analyst Ratings For Amgen ↗
 
Via Benzinga
News headline image
Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review ↗
The major indexes declined, but haven't fallen apart. 
Via Investor's Business Daily
News headline image
Amgen (AMGN) Q3 2024 Earnings Call Transcript ↗
AMGN earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO ↗
The company expects to have topline results from a Phase 2 study later this year. 
Via Investor's Business Daily
News headline image
Is Amgen Stock a Buy? ↗
This biotech leader could be poised to rally higher. 
Via The Motley Fool
News headline image
Looking Into Amgen's Recent Short Interest ↗
 
Via Benzinga
News headline image
In-Depth Examination Of 11 Analyst Recommendations For Amgen ↗
 
Via Benzinga
News headline image
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday? ↗
Risk aversion swept across markets on Thursday as investor disappointment over third-quarter tech earnings triggered the steepest drop in major U.S. indices in nearly two months. 
Via Benzinga
News headline image
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights ↗
Novartis aims to enhance Pluvicto's market presence while exploring growth in multiple sclerosis and expanding its radioligand therapy portfolio. 
Via Benzinga
News headline image
Wall Street Mixed, Semiconductors Tumble As AMD Disappoints, Alphabet Rallies, SMCI Plummets: What's Driving Markets Wednesday? ↗
Wall Street experienced a mixed trading session on Wednesday as investors weigh a batch of corporate earnings and fresh economic data. 
Via Benzinga
News headline image
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split ↗
One of these players has split its stock in the past. The other one hasn't. 
Via The Motley Fool
News headline image
What Lies In Store For Healthcare ETFs In Q3 Earnings? ↗
The healthcare sector has performed well in recent months, driven by the booming weight-loss drug treatment segment. As such, various healthcare ETFs have benefited. 
Via Talk Markets
Topics ETFs
News headline image
2 Reliable Dividend Stocks You Can Buy and Hold Forever ↗
There are reasons beyond the dividends to invest in these stocks. 
Via The Motley Fool
News headline image
Top Stock Reports For Costco, Coca-Cola & T-Mobile US ↗
Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corp., The Coca-Cola Co., and T-Mobile US, Inc., as well as a micro-cap stock Preformed Line Products... 
Via Talk Markets
News headline image
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition ↗
Roche reported a 9% increase in third-quarter sales, driven by strong performance from Ocrevus and Vabysmo. Roche also raised concerns over the Catalent acquisition. 
Via Benzinga
News headline image
Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade ↗
The analyst is closely watching MariTide, a potential monthly injection to treat obesity. 
Via Investor's Business Daily
News headline image
Blue Skies, New Highs Remain Disciplined And Do Not Chase Extended Ideas ↗
It is Fall clean up time. Sell lagging and sagging companies. 
Via Talk Markets
News headline image
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names ↗
The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's dominance while addressing scalability and pricing concerns. 
Via Benzinga
News headline image
2 Top Dividend Stocks to Buy Hand Over Fist Right Now ↗
Income stocks can be wise additions to your portfolio in any market environment. 
Via The Motley Fool
News headline image
18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' ↗
Goldman Sachs identifies 18 stocks for potential earnings upside and advises options-based strategies in a volatile market. 10% upside for S&P 500. 
Via Benzinga
Topics Stocks
News headline image
Deere, Amgen, Copart And More: CNBC's 'Final Trades' ↗
On CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Deere & Company as his final trade. 
Via Benzinga
News headline image
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients ↗
The Biden administration's proposed Medicare $2 Drug List Model aims to provide low-cost generic drugs for seniors and people with disabilities, with copayments capped at $2 per month for essential... 
Via Benzinga
News headline image
2 Biotech Stocks to Buy Hand Over Fist in October ↗
These longtime leading biotech stocks still have plenty of upside ahead. 
Via The Motley Fool
News headline image
Want to Invest in the Weight Loss Boom? Consider Buying These 2 Stocks ↗
Investing in the most popular players in the space isn't the only valid approach. 
Via The Motley Fool
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
69 70 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.